Updated:
Eclosion Ventures
Eclosion Ventures is a Geneva-based life-science investment fund that builds early-stage biotech companies from discovery to clinical proof of concept.
Eclosion Ventures
Eclosion Ventures is a private equity firm based in Geneva, Switzerland. It focuses on a Venture Capital investment approach.
General information
Firm type
Venture Capital
Year founded
2004
Location
Region
Europe
Country
Switzerland
City
Geneva
Corporate office
Campus Biotech – Innovation Park (F2), Avenue de Sécheron 15, 1202 Geneva, Switzerland
Sector focus
Frequently asked questions
What investment stages does Eclosion Ventures target?
Eclosion invests at the seed stage and supports portfolio companies through to clinical proof of concept. The firm makes a long-term operational and financial commitment from company formation, rather than entering at later venture rounds.
Which therapeutic areas does Eclosion Ventures focus on?
The firm's portfolio has developed first-in-class drug candidates addressing multiple sclerosis, fibrosis, and oncology. Eclosion targets early-stage science with the potential to create transformative, best-in-disease therapeutics.
Does Eclosion Ventures participate in fund commitments or only direct deals?
Eclosion operates as a direct investor. The firm builds and capitalizes startups itself rather than committing to third-party venture funds. It does not describe any fund-of-funds activity.
How is Eclosion Ventures structured?
Eclosion manages a dedicated life-science fund from a single office in Geneva, Switzerland. The firm has not disclosed a parent entity, multi-asset platform, or parallel vehicles, making it a focused, single-strategy biotech investor.
Who runs investment decisions at Eclosion Ventures?
Eclosion states it is led by an experienced management team combining scientific, operational and financial expertise, but it has not publicly named its investment principals or decision-makers.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: